Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion.
暂无分享,去创建一个
[1] N. Chen,et al. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. , 2010, Journal of neurosurgery. Spine.
[2] T. Albert,et al. Complications associated with single-level transforaminal lumbar interbody fusion. , 2009, The spine journal : official journal of the North American Spine Society.
[3] S. Glassman,et al. Perioperative Complications of Recombinant Human Bone Morphogenetic Protein-2 on an Absorbable Collagen Sponge Versus Iliac Crest Bone Graft for Posterior Cervical Arthrodesis , 2009, Spine.
[4] R. Vaidya,et al. Complications in the Use of rhBMP-2 in PEEK Cages for Interbody Spinal Fusions , 2008, Journal of spinal disorders & techniques.
[5] S. Jatana,et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). , 2008, The spine journal : official journal of the North American Spine Society.
[6] U. Mansmann,et al. Posterior lumbar interbody fusion using rhBMP-2 , 2008, European Spine Journal.
[7] Y. R. Rampersaud,et al. Heterotopic Bone Formation With the Use of rhBMP2 in Posterior Minimal Access Interbody Fusion: A CT Analysis , 2007, Spine.
[8] T. Albert,et al. 10. BMP-2 Causes Increased Postoperative Radiculitis Following TLIF , 2007 .
[9] S. Kelley. The Adult Hip. 2nd ed. , 2007 .
[10] J. Reynolds,et al. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes. , 2007, The spine journal : official journal of the North American Spine Society.
[11] N. Anand,et al. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. , 2007, The spine journal : official journal of the North American Spine Society.
[12] Joseph D. Smucker,et al. Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical Spine , 2006, Spine.
[13] J. McClellan,et al. Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2) , 2006, Journal of spinal disorders & techniques.
[14] R. Delamarter,et al. Controlling Bone Morphogenetic Protein Diffusion and Bone Morphogenetic Protein-Stimulated Bone Growth Using Fibrin Glue , 2006, Spine.
[15] S. Glassman,et al. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.
[16] K. Bulsara,et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. , 2005, Journal of neurosurgery. Spine.
[17] T. Albert,et al. Timing of surgical stabilization after cervical and thoracic trauma. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2005, Journal of neurosurgery. Spine.
[18] R. Welch,et al. Recombinant Human Bone Morphogenic Protein-2-Enhanced Anterior Spine Fusion Without Bone Encroachment Into the Spinal Canal: A Histomorphometric Study in a Thoracoscopically Instrumented Porcine Model , 2005, Spine.
[19] C. Branch,et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.
[20] I. Kalajzic,et al. Role of B Lymphocytes in New Bone Formation , 2000, Laboratory Investigation.
[21] L. Titus,et al. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.
[22] I. Lukić,et al. Genetic variability of new bone induction in mice. , 1999, Bone.
[23] John J. Callaghan,et al. The Adult Hip , 1997 .